Cellectis S.A. - American Depositary Shares - dividendos trimestrais (NASDAQ:CLLS) | MetaTrader

Abrir gráfico completo

Cellectis S.A. - American Depositary Shares

Cellectis is a French biopharmaceutical company. It develops genome-edited chimeric antigen receptor T-cell technologies for cancer immunotherapy. It has offices in Paris, New York City, and Raleigh, North Carolina.

Notícias

Ações da Cellectis mantêm classificação de desempenho superior com base na plataforma alogênica

Citizens reitera classificação das ações da Cellectis com base no progresso CAR-T

Cellectis supera previsões do 4º tri de 2025 e ação sobe

Lucro da Cellectis superou projeções por $0,10; receita supera estimativas

Jefferies assume cobertura das ações da Cellectis com recomendação de compra

Jefferies assumes coverage on Cellectis stock with Buy rating

This Levi Strauss Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Tuesday - Brunswick (NYSE:BC), Cellectis (NASDAQ:CLLS)

Clear Street inicia cobertura da Cellectis com recomendação de compra

Clear Street initiates Cellectis stock with Buy rating on CAR-T potential

Cellectis: Showcasing Encouraging Data, But Still Early To Make A Run Like This (CLLS)

Allogene Arbitration Victory Pressures Cellectis Shares Tuesday - Allogene Therapeutics (NASDAQ:ALLO), Cellectis (NASDAQ:CLLS)

Lightwave Logic, Kyverna Therapeutics And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session - Argo Blockchain (NASDAQ:ARBK), Ascent Solar Technologies (NASDAQ:ASTI)